Research

Scientists with the Walter Reed Army Institute of Research (WRAIR) have found that immunizing nurse sharks with experimental SARS-CoV-2 vaccines elicited a set of unique nano-sized antibodies that broadly neutralize a range of viruses in the SARS-CoV family and confer passive immune protection in a mouse virus challenge model. Findings were published in Nature Communications.

EIDB is leveraging WRAIR’s ID countermeasure infrastructure and expertise to compress what would be years of discovery and design work into several months

COVID-19

MERS

Hemorrhagic fevers are a family of infectious diseases including Ebola, Marburg, Lassa fever and yellow fever that affect the body’s blood clotting abilities. Recent outbreaks have occurred in militarily strategic regions like West Africa where WRAIR’s research infrastructure has enabled surveillance and countermeasure research.

Ebola

Lassa Fever

Marburg

WRAIR continues to leverage its expertise in flaviviruses to improve solutions for century-old infectious disease threats, like yellow fever, and to innovate new products to combat new and re-emerging pathogens like Zika virus.

Tick-borne Encephalitis

Yellow Fever

Zika

WRAIR Researchers Identify Nano-sized Antibodies in Sharks Able to Broadly and Potently Neutralize a Range of Sarbecoviruses

A Forward-Thinking Approach to Coronaviruses

Advancing Countermeasures Against Hemorrhagic Fevers

Flavivirus Threats Persist